Alpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)
2010

Alpha-1 Antitrypsin Gene Variants and COPD

Sample size: 300 publication Evidence: low

Author Information

Author(s): Denden Sabri, Khelil Amel Haj, Knani Jalel, Lakhdar Ramzi, Perrin Pascale, Lefranc Gérard, Chibani Jemni Ben

Primary Institution: Biochemistry and Molecular Biology Laboratory, Faculty of Pharmacy, Monastir, Tunisia

Hypothesis

Common AAT polymorphisms influence the risk of developing COPD.

Conclusion

The study found no significant differences in the frequency of common SERPINA1 variants between COPD patients and healthy controls.

Supporting Evidence

  • No significant differences were observed in allele frequencies between COPD patients and controls.
  • Haplotype analysis showed no significant differences between the two groups.
  • Annual FEV1 decline revealed no difference among carriers of the tested polymorphisms.

Takeaway

This study looked at whether certain gene variations affect the risk of getting COPD, but it found that they don't seem to make a difference.

Methodology

A case-control study comparing allele frequencies and haplotypes between 100 COPD patients and 200 healthy controls.

Limitations

The study excluded AATD individuals and did not find significant relationships between the tested polymorphisms and COPD manifestations.

Participant Demographics

100 COPD patients and 200 healthy controls, with specific inclusion and exclusion criteria.

Digital Object Identifier (DOI)

10.1590/S1415-47572009005000107

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication